Jane Street Group, LLC Vertex Pharmaceuticals Inc Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Jane Street Group, LLC holds 54,192 shares of VRTX stock, worth $22.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

54,192

Previous 303,666 82.15%

Holding current value

$22.1 Million

Previous $142 Million 82.29%

% of portfolio

0.01%

Previous 0.16%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$460.0 - $505.78 $115 Million - $126 Million	-249,474 Reduced 82.15%	54,192 $25.2 Million
Q2 2024 Aug 14, 2024	BUY	$392.81 - $485.53 $63.3 Million - $78.2 Million	161,058 Added 112.94%	303,666 $142 Million
Q1 2024 May 15, 2024	SELL	$407.69 - $446.08 $12.7 Million - $13.9 Million	-31,151 Reduced 17.93%	142,608 $59.6 Million
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $38.9 Million - $46.6 Million	113,416 Added 187.95%	173,759 $70.7 Million
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $10.8 Million - $11.6 Million	31,869 Added 111.92%	60,343 $21 Million
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $2.12 Million - $2.37 Million	6,735 Added 30.98%	28,474 $10 Million
Q1 2023 May 15, 2023	SELL	$283.23 - $323.1 $365,366 - $416,799	-1,290 Reduced 5.6%	21,739 $6.85 Million
Q4 2022 Feb 14, 2023	SELL	$285.76 - $321.48 $2.86 Million - $3.22 Million	-10,017 Reduced 30.31%	23,029 $6.65 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $2.84 Million - $3.17 Million	10,370 Added 45.73%	33,046 $9.57 Million
Q2 2022 Aug 16, 2022	BUY	$234.96 - $292.55 $1.35 Million - $1.68 Million	5,752 Added 33.99%	22,676 $6.39 Million
Q1 2022 May 17, 2022	SELL	$221.42 - $260.97 $10.9 Million - $12.8 Million	-49,144 Reduced 74.38%	16,924 $4.42 Million
Q4 2021 Feb 15, 2022	SELL	$177.01 - $223.45 $12.2 Million - $15.5 Million	-69,179 Reduced 51.15%	66,068 $14.5 Million
Q3 2021 Nov 16, 2021	SELL	$181.39 - $202.99 $7.08 Million - $7.93 Million	-39,047 Reduced 22.4%	135,247 $24.5 Million
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $11.8 Million - $14 Million	63,114 Added 56.77%	174,294 $35.1 Million
Q1 2021 May 18, 2021	BUY	$207.02 - $241.31 $1.73 Million - $2.01 Million	8,347 Added 8.12%	111,180 $23.9 Million
Q4 2020 Feb 17, 2021	BUY	$207.01 - $276.09 $10.5 Million - $14.1 Million	50,900 Added 98.01%	102,833 $24.3 Million
Q3 2020 Nov 17, 2020	BUY	$255.65 - $303.1 $10.3 Million - $12.3 Million	40,423 Added 351.2%	51,933 $14.1 Million
Q2 2020 Aug 17, 2020	SELL	$225.48 - $295.8 $859,304 - $1.13 Million	-3,811 Reduced 24.87%	11,510 $3.34 Million
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $1.3 Million - $1.61 Million	6,495 Added 73.59%	15,321 $3.65 Million
Q4 2019 Feb 14, 2020	SELL	$166.71 - $223.91 $898,900 - $1.21 Million	-5,392 Reduced 37.92%	8,826 $1.93 Million
Q3 2019 Nov 14, 2019	BUY	$166.23 - $187.09 $614,552 - $691,671	3,697 Added 35.14%	14,218 $2.41 Million
Q2 2019 Aug 15, 2019	SELL	$164.61 - $190.37 $577,287 - $667,627	-3,507 Reduced 25.0%	10,521 $1.93 Million
Q1 2019 May 16, 2019	BUY	$163.73 - $194.7 $1.27 Million - $1.52 Million	7,785 Added 124.7%	14,028 $2.58 Million
Q4 2018 Feb 15, 2019	SELL	$151.91 - $192.21 $4.63 Million - $5.85 Million	-30,459 Reduced 82.99%	6,243 $1.04 Million
Q3 2018 Nov 14, 2018	SELL	$167.73 - $192.74 $2.95 Million - $3.39 Million	-17,580 Reduced 32.39%	36,702 $7.07 Million
Q2 2018 Aug 15, 2018	BUY	$145.72 - $169.96 $4.94 Million - $5.76 Million	33,885 Added 166.13%	54,282 $9.23 Million
Q1 2018 May 15, 2018	BUY	$151.6 - $177.13 $2.21 Million - $2.58 Million	14,581 Added 250.7%	20,397 $3.33 Million
Q4 2017 Feb 15, 2018	SELL	$137.28 - $155.55 $883,945 - $1 Million	-6,439 Reduced 52.54%	5,816 $872,000
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $1.82 Million - $1.99 Million	12,255	12,255 $1.86 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Vertex Pharmaceuticals Inc Transaction History